Paranta Biosciences Develops Novel Biotherapeutics Based On Recombinant Human Follistatin To Treat Conditions Involving Inflammation And Fibrosis
No conferences found for this company.
| Company Name | Paranta Biosciences Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.